This act is the first that Joan Massagu\u00e9 undertakes as an honorary academic of the Catalan Royal Academy of Pharmacy, an award that this academy granted last December in recognition of his prestigious relevance in work performed in pharmaceutical science. The researcher is shortly to assume the direction of a new oncological research programme on metastasis at the Institute of Biomedical Research of the PCB, which will include the “Tumour Metastasis Research Laboratory” (METLAB).<\/p>\n
Joan Massagu\u00e9 (Barcelona, 1953) holds a Ph.D. in Pharmacy (Biochemisrty) from the Universitat de Barcelona. In 1978, he moved to Brown University, on Rhode Island (USA), where he discovered the structure of the insulin receptor. At present, he directs the Cancer Biology and Genetics Programme at the Memorial Sloan-Kettering Cancer Center and is also a researcher at Howard Hughes Medical Institute in New York. In his teaching capacity, Joan Massagu\u00e9 is a professor at the Well Graduate School of Medical Sciences. <\/p>\n
Joan Massagu\u00e9 is the principal researcher in lines on the regulation of cell division and cancer metastasis, author of some 250 scientific articles on these topics, and one of the fifty most cited investigators in all scientific fields in the last twenty years. His research has been crucial for improving our knowledge of mechanisms that allow the arrest of cell proliferation, a process that, when dysregulated, leads to the formation of tumours. In addition, his studies have allowed the identification of genes that control metastasis of human breast cancer cells to other organs; a milestone that opens up new research possibilities on this aspect of cancer. <\/p>\n
Among other references, Joan Massagu\u00e9 has received more that twenty-five awards, including the Prince of Asturias Prize, the King Juan Carlos I National Research Award and the Howard Taylor Ricketts Award. The researcher is also an elected member of the US National Academy of Sciences, the American Academy of Arts and Sciences, the European Molecular Biology Organization and the Spanish Royal Academies of Medicine and Pharmacy. <\/p>\n","protected":false},"excerpt":{"rendered":"